Skip to content

Guarddog Occlusion System, Occlusion Guidewire, 300 Cm, Guarddog Occlusion System Occlusion Guidewire, 200 Cm

by Possis Medical, Inc.

510(k) K031357

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK031357 Date18 May 2004ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MJN
Device Class
Class II
Regulation
21 CFR Part 870.4450
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The GuardDOG Occlusion System Occlusion Guidewire is a Catheter, Intravascular Occluding, Temporary designed for temporary vascular occlusion. It features a 0.014-inch diameter guidewire with a distal compliant elastomer balloon, enabling localized vessel occlusion during interventional procedures in peripheral vasculature. The system is intended for use in controlled clinical settings where precise occlusion is required for therapeutic or diagnostic interventions.

The device is supplied as a reusable occlusion guidewire paired with a CO₂ inflation device, ensuring sterile handling and single-use per procedure. It is classified under FDA 510(k) clearance (K031357) as a Class II medical device under product code MJN. The system is intended for use in peripheral vasculature, with lengths of 200 cm and 300 cm available, and adheres to regulatory standards for intravascular occlusion devices.

Other devices from Possis Medical, Inc.

See all devices from Possis Medical, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the GuardDOG Occlusion Guidewire used for?

    The GuardDOG Occlusion Guidewire is designed for temporary vascular occlusion in peripheral vasculature during interventional procedures. Its 0.014-inch diameter guidewire with a distal compliant elastomer balloon allows localized vessel occlusion, enabling controlled therapeutic or diagnostic interventions where precise isolation of blood flow is required.

  • How is the GuardDOG Occlusion System supplied, and is it reusable?

    The GuardDOG Occlusion System is supplied as a reusable occlusion guidewire paired with a CO₂ inflation device. However, the guidewire itself is intended for single-use per procedure to ensure sterile handling and patient safety. The inflation device is designed for repeated use across multiple procedures.

  • What lengths are available for the GuardDOG Occlusion Guidewire?

    The GuardDOG Occlusion Guidewire is available in two lengths: 200 cm and 300 cm. These lengths accommodate varying procedural needs in peripheral vasculature, ensuring flexibility for different anatomical requirements.

  • Is the GuardDOG Occlusion Guidewire sterile, and how should it be stored?

    Yes, the GuardDOG Occlusion Guidewire is supplied sterile for single-use per procedure. It should be stored in a clean, dry environment, protected from physical damage and contamination. Follow manufacturer guidelines for proper packaging and storage conditions to maintain sterility and functionality.

  • What regulatory pathway does the GuardDOG Occlusion System follow?

    The GuardDOG Occlusion System has received FDA 510(k) clearance (K031357) as a Class II medical device under product code MJN. This clearance confirms its substantial equivalence to a predicate device and compliance with regulatory standards for intravascular occlusion devices in the United States.